tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market

Akebia Therapeutics (AKBA) Income Statement

Compare
1,402 Followers

Akebia Therapeutics Income Statement

Last quarter (Q4 2024), Akebia Therapeutics's total revenue was $46.50M, a decrease of -17.26% from the same quarter last year. In Q4, Akebia Therapeutics's net income was $-22.80M. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 160.18M$ 194.62M$ 292.60M$ 213.58M$ 295.31M
Gross Profit
$ 97.00M$ 120.47M$ 207.81M$ 60.18M$ -601.00K
Operating Expenses
$ 147.47M$ 166.73M$ 270.99M$ 325.50M$ 375.84M
Depreciation and Amortization
$ 36.75M$ 37.63M$ 35.28M$ 36.13M$ 33.59M
EBITDA
$ -13.72M$ -6.87M$ -43.26M$ -225.96M$ -341.00M
Operating Income
$ -50.47M$ -46.26M$ -63.18M$ -265.32M$ -376.44M
Other Income/Expenses
$ -18.94M$ -5.67M$ -13.45M$ -17.52M$ -5.63M
Pretax Income
$ -69.41M$ -51.92M$ -92.56M$ -282.84M$ -383.46M
Net Income
$ -69.41M$ -51.92M$ -106.01M$ -244.87M$ -349.87M
Per Share Metrics
Basic EPS
$ -0.33$ -0.28$ -0.58$ -1.48$ -2.53
Diluted EPS
$ -0.33$ -0.28$ -0.58$ -1.48$ -2.53
Weighted Average Shares Outstanding
210.95M 187.47M 182.78M 165.95M 138.46M
Weighted Average Shares Outstanding (Diluted)
210.95M 187.47M 182.78M 165.95M 138.46M
Currency in USD

Akebia Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis